Similar Search Results

Venture-Capital-Finanzierung eines Biotechnologieunternehmens

Berens, Wolfgang; Hoffjan, Andreas; Pakulla, Regina - In: Wirtschaftswissenschaftliches Studium : WiSt ; … 29 (2000) 5, pp. 297-300

Persistent link: https://www.econbiz.de/10001469142

Venture Capitalists' Selection Process : The Case of Biotechnology Proposals

Baeyens, Katleen - 2014

The goal of this research is to determine how the riskynature of biotechnology ventures influences the investment …

Persistent link: https://www.econbiz.de/10013070627

The Covid-19 pandemic and the importance of financing the biotechnology industry in South Africa

Uctu, Ramazan; Eksteen, Karen - In: Journal of entrepreneurial finance : JEF ; official … 24 (2022) 1, pp. 69-94

African biotechnology industry requires funding for the biotechnology industry. Our goal with this research is to look into … policymakers with a clear image of the importance of funding the biotechnology sector, notably during the Covid-19 period, as … biotechnology eco-system to understand the role of biotechnology funding, notably during the Covid-19 pandemic. Overall …

Persistent link: https://www.econbiz.de/10012990143

Connected VCs and strategic alliances : evidence from biotech companies

Brinster, Leonhard; Tykvová, Tereza - In: The journal of corporate finance : contracting, … 66 (2021), pp. 1-17

Persistent link: https://www.econbiz.de/10012514677

Spotlight on Biotechnology : valuation challenges of early-stage companies. A case study on CRISPR Therapeutics AG and Allakos, Inc

Montagna, Dennis Marco; Fino, Emanuele; Nocera, Giovanni; … - 2021

High volatility, no predictable cash flows and technological uncertainties make Biotech-Healthcare companies’ valuation a challenging task for analysts and investors. Translating clinical promises into economic value represents a rough obstacle of this attractive business, especially in...

Persistent link: https://www.econbiz.de/10013252434